These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21306567)

  • 1. Synthesis and antiviral evaluation of new N-acylhydrazones containing glycine residue.
    Tian B; He M; Tan Z; Tang S; Hewlett I; Chen S; Jin Y; Yang M
    Chem Biol Drug Des; 2011 Mar; 77(3):189-98. PubMed ID: 21306567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
    Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV evaluation of benzo[d]isothiazole hydrazones.
    Vicini P; Incerti M; La Colla P; Loddo R
    Eur J Med Chem; 2009 Apr; 44(4):1801-7. PubMed ID: 18614259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
    Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
    Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly.
    Fader LD; Bethell R; Bonneau P; Bös M; Bousquet Y; Cordingley MG; Coulombe R; Deroy P; Faucher AM; Gagnon A; Goudreau N; Grand-Maître C; Guse I; Hucke O; Kawai SH; Lacoste JE; Landry S; Lemke CT; Malenfant E; Mason S; Morin S; O'Meara J; Simoneau B; Titolo S; Yoakim C
    Bioorg Med Chem Lett; 2011 Jan; 21(1):398-404. PubMed ID: 21087861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some hydrazones of 2-aroylamino-3-methylbutanohydrazide: synthesis, molecular modeling studies, and identification as stereoselective inhibitors of HIV-1.
    Tatar E; Küçükgüzel I; Daelemans D; Talele TT; Kaushik-Basu N; De Clercq E; Pannecouque C
    Arch Pharm (Weinheim); 2013 Feb; 346(2):140-53. PubMed ID: 23280502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
    Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
    Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
    J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead optimization of diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Zeng ZS; Liang YH; Feng XQ; Chen FE; Pannecouque C; Balzarini J; De Clercq E
    ChemMedChem; 2010 Jun; 5(6):837-40. PubMed ID: 20333620
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.
    Zhan P; Liu X; Li Z; Fang Z; Li Z; Wang D; Pannecouque C; Clercq ED
    Bioorg Med Chem; 2009 Aug; 17(16):5920-7. PubMed ID: 19620009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Qin H; Liu C; Zhang J; Guo Y; Zhang S; Zhang Z; Wang X; Zhang L; Liu J
    Bioorg Med Chem Lett; 2010 May; 20(9):3003-5. PubMed ID: 20347295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
    Fader LD; Landry S; Morin S; Kawai SH; Bousquet Y; Hucke O; Goudreau N; Lemke CT; Bonneau P; Titolo S; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3396-400. PubMed ID: 23583513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.
    Bonache MC; Chamorro C; Velázquez S; De Clercq E; Balzarini J; Barrios FR; Gago F; Camarasa MJ; San-Félix A
    J Med Chem; 2005 Oct; 48(21):6653-60. PubMed ID: 16220981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
    Le Van K; Cauvin C; de Walque S; Georges B; Boland S; Martinelli V; Demonté D; Durant F; Hevesi L; Van Lint C
    J Med Chem; 2009 Jun; 52(12):3636-43. PubMed ID: 19469474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Liang YH; Feng XQ; Zeng ZS; Chen FE; Balzarini J; Pannecouque C; De Clercq E
    ChemMedChem; 2009 Sep; 4(9):1537-45. PubMed ID: 19591191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhan P; Liu X; Zhu J; Fang Z; Li Z; Pannecouque C; Clercq ED
    Bioorg Med Chem; 2009 Aug; 17(16):5775-81. PubMed ID: 19643613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
    Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
    ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
    Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
    J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.
    Mugnaini C; Manetti F; Esté JA; Clotet-Codina I; Maga G; Cancio R; Botta M; Corelli F
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3541-4. PubMed ID: 16621553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.